O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+5.97%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.28B
AUM Growth
+$8.28B
(+5.4%)
Cap. Flow
+$285M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
35.4%
Holding
137
New
11
Increased
41
Reduced
26
Closed
12
Top Buys
| 1 |
Ironwood Pharmaceuticals
IRWD
|
$120M |
| 2 |
CELG
Celgene Corp
CELG
|
$110M |
| 3 |
SHPG
Shire pic
SHPG
|
$74.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
$73.6M |
| 5 |
TRNX
TORNIER N V SHARES (NLD)
TRNX
|
$60.8M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$156M |
| 2 |
AGN
ALLERGAN INC
AGN
|
$123M |
| 3 |
Prothena Corp
PRTA
|
$72.4M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$60M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$57.6M |
Sector Composition
| 1 | Healthcare | 84.96% |
| 2 | Financials | 0.08% |
| 3 | Technology | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
McKesson
MCK
$85.4B
| $123M | 1.44% | 660,000 +81,000 | +14% | +$15.1M |
|
27
Zimmer Biomet
ZBH
$21B
| $122M | 1.44% | 1,178,700 +462,500 | +65% | +$48M |
|
28
Pfizer
PFE
$141B
| $121M | 1.42% | 4,082,000 +421,000 | +11% | +$12.5M |
|
|
HNT
29
DELISTED
HEALTH NET INC
HNT
| $119M | 1.4% | 2,875,400 +315,400 | +12% | +$13.1M |
|
|
AGN
30
DELISTED
Allergan plc
AGN
| $119M | 1.39% | 532,000 +37,000 | +7% | +$8.25M |
|
|
STJ
31
DELISTED
St Jude Medical
STJ
| $115M | 1.35% | 1,663,600 +517,000 | +45% | +$35.8M |
|
32
Molina Healthcare
MOH
$9.8B
| $114M | 1.34% | 2,562,900 +309,900 | +14% | +$13.8M |
|
|
TRNX
33
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $95.2M | 1.12% | 4,073,800 +2,598,700 | +176% | +$60.8M |
|
|
34
Regeneron Pharmaceuticals
REGN
$61.5B
| $92.3M | 1.08% | 326,600 -212,400 | -39% | -$60M |
|
35
BioMarin Pharmaceuticals
BMRN
$11.2B
| $89.3M | 1.05% | 1,435,400 -57,600 | -4% | -$3.58M |
|
36
Stryker
SYK
$150B
| $83.9M | 0.98% | 994,600 +367,900 | +59% | +$31M |
|
37
Insulet
PODD
$23.9B
| $77.5M | 0.91% | 1,953,000 +19,500 | +1% | +$774K |
|
38
Arrowhead Research
ARWR
$3.05B
| $70.9M | 0.83% | 4,957,800 +1,047,800 | +27% | +$15M |
|
39
Neurocrine Biosciences
NBIX
$13.8B
| $69.4M | 0.81% | 4,675,700 -775,300 | -14% | -$11.5M |
|
|
INFI
40
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $60.3M | 0.71% | 4,736,900 | – | – |
|
|
AFFX
41
DELISTED
AFFYMETRIX INC
AFFX
| $58.5M | 0.69% | 6,568,000 -125,000 | -2% | -$1.11M |
|
42
Standard BioTools
LAB
$481M
| $54.7M | 0.64% | 1,862,200 +415,000 | +29% | +$12.2M |
|
43
Johnson & Johnson
JNJ
$427B
| $50.4M | 0.59% | 482,000 -115,000 | -19% | -$12M |
|
44
Vertex Pharmaceuticals
VRTX
$100B
| $50M | 0.59% | 528,000 +368,000 | +230% | +$34.8M |
|
|
ALXN
45
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $48.8M | 0.57% | 312,000 +45,000 | +17% | +$7.03M |
|
46
OraSure Technologies
OSUR
$242M
| $46.3M | 0.54% | 5,372,000 | – | – |
|
|
PTLA
47
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $39.7M | 0.47% | 1,361,600 +403,900 | +42% | +$11.8M |
|
48
Celldex Therapeutics
CLDX
$1.47B
| $35.6M | 0.42% | 2,181,600 -166,000 | -7% | -$2.71M |
|
49
Xtant Medical Holdings
XTNT
$83.3M
| $32.1M | 0.38% | 4,754,386 | – | – |
|
|
DRTX
50
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
| $30.4M | 0.36% | 1,785,714 | – | – |
|